NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Fonterra spinoff's $3.2b capital return
Primary Sector

Fonterra spinoff's $3.2b capital return

Farmers will vote on the $4b deal in October.

Riley Kennedy 26 Aug 2025
Supply chain inefficiencies stymieing NZ exporters
Policy

Supply chain inefficiencies stymieing NZ exporters

“We are paying 50-60% more to get our freight to India.” 

Oliver Lewis 25 Aug 2025
My Net Worth: Leeann Watson, Business Canterbury CEO
Editor's Picks

My Net Worth: Leeann Watson, Business Canterbury CEO

Leeann Watson learned the value of hard work and being open-minded from her parents.

Cécile Meier 24 Aug 2025
On The Money: CSI Hawkesby, Mainland, and more ...
Editor's Picks

On The Money: CSI Hawkesby, Mainland, and more ...

Fonterra dumps Mainland, an AI Gareth Morgan and Mark Lister, plus CSI: RBNZ.

Dileepa Fonseka 23 Aug 2025